Kinfo
Ani Pharmaceuticals, Inc. logo

Ani Pharmaceuticals, Inc.

ANIPNASDAQHealthcare·US · USD
$72.67
+0.49 (+0.68%)
Prices as of October 5, 2026 · live

Price

Key statistics

Valuation
Market cap1.66B USD
Enterprise value1.80B USD
Trailing P/E15.73
Forward P/E6.94
PEG ratio0.08
Price / sales1.69
Price / book2.59
Profitability
Gross margin62.35%
Operating margin14.97%
Profit margin11.07%
Return on assets5.45%
Return on equity20.46%
Income (TTM)
Revenue978.38M USD
Gross profit590.98M USD
EBITDA215.19M USD
Net income99.60M USD
Diluted EPS$4.59
Rev. growth (YoY)25.90%
Balance sheet
Total cash376.96M USD
Total debt626.03M USD
Debt / equity104.83
Current ratio2.91
Book value / share$27.87
Cash flow (TTM)
Operating cash flow189.47M USD
Levered free cash flow132.21M USD
Shares & price
Shares outstanding22.97M
Float19.66M
Held by institutions107.11%
Beta0.45
50-day MA$75.44
200-day MA$78.56
52-week high$97.00
52-week low$69.58
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-072.042.21+8.33%2026-06-25-0.14-0.16−14.29%2026-05-081.302.05+57.69%2026-03-040.060.15+150.00%
About Ani Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and commercializes branded, generic, and specialty prescription medicines. ANI Pharmaceuticals focuses on three main areas: Rare Disease, Generics, and Established Brands. Its portfolio includes therapies for ophthalmology, rheumatology, nephrology, neurology, and pulmonology, alongside a broad range of generic products and established branded medicines. The company also supports contract manufacturing and pharmaceutical development services, leveraging U.S.-based manufacturing capabilities and expertise in complex formulations such as injectables, softgels, oral solids, liquids, and topical products. ANI Pharmaceuticals serves patients, pharmacies, wholesalers, specialty channels, and other healthcare customers through a diversified commercial model built around prescription pharmaceuticals and niche therapeutic markets.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Nikhil Lalwani
Employees
970
Headquarters
Baudette, MN, United States

Frequently asked questions about Ani Pharmaceuticals, Inc.